PMH20 PSYCHOTROPIC MEDICATION USE AMONG CHILDREN WITH AUTISM SPECTRUM DISORDER- A COMPARISON BETWEEN MEDICAID AND COMMERCIAL INSURANCE
May 1, 2011, 00:00
10.1016/j.jval.2011.02.1044
https://www.valueinhealthjournal.com/article/S1098-3015(11)01183-1/fulltext
Title :
PMH20 PSYCHOTROPIC MEDICATION USE AMONG CHILDREN WITH AUTISM SPECTRUM DISORDER- A COMPARISON BETWEEN MEDICAID AND COMMERCIAL INSURANCE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)01183-1&doi=10.1016/j.jval.2011.02.1044
First page :
A189
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
522